日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Regulation of transcription by R loop-nucleated transcription condensate assembly

R环成核转录凝聚体组装对转录的调控

Ng, Raissa Regina; Lin, Zhongyang; Tan, Heng Wee; Xu, Yan-Ming; Lau, Andy T Y

Correction: Elucidating the role of N‑myristoylation in the excessive membrane localization of PD‑L1 in hypoxic cancers and developing a novel NMT1 inhibitor for combination with immune checkpoint blockade therapy.

更正:阐明 N'肉豆蔻酰化在缺氧癌症中 PD'L1 过度膜定位中的作用,并开发一种新型 NMT1 抑制剂与免疫检查点阻断疗法联合使用

Zhao Haoming, Zhang Zhen, Zhang Chaojun, Ma Hexin, Wan Qingqing, Zhao Xinran, Wang Xu, Yan Ming, Guo Haiyan, Zhang Jianjun, Chen Wantao

Deciphering 17-β-hydroxysteroid dehydrogenase 4: from molecular insights to cancer therapeutics

解读17-β-羟基类固醇脱氢酶4:从分子层面的见解到癌症治疗

Liao, Meng-Bin; Lau, Andy T Y; Xu, Yan-Ming

Common bean pan-genome reveals abundant variation patterns and relationships of stress response genes and pathways

普通豆泛基因组揭示了丰富的应激反应基因和通路变异模式及相互关系

Wang, Xu; Yan, Ming; Cui, Shanshan; Li, Fang; Zhao, Qingqing; Wang, Qingnan; Jiang, Bin; Huang, Yixin; Sun, Yang; Kong, Xiangdong

Chromosome X Open Reading Frame 38 (CXorf38) Is a Tumor Suppressor and Potential Prognostic Biomarker in Lung Adenocarcinoma: The First Characterization.

X染色体开放阅读框38(CXorf38)是肺腺癌的肿瘤抑制因子和潜在预后生物标志物:首次表征

Yan Rui, Tan Heng-Wee, Cai Na-Li, Yu Le, Gao Yan, Xu Yan-Ming, Lau Andy T Y

The regulation of microRNAs on chemoresistance in triple-negative breast cancer: a recent update

microRNA在三阴性乳腺癌化疗耐药中的调控:最新进展

Yan, Li-Jun; Y Lau, Andy T; Xu, Yan-Ming

The Epigenetic Effects of Coffee

咖啡的表观遗传效应

Ding, Qi; Xu, Yan-Ming; Lau, Andy T Y

Epigenetic effects of herbal medicine

草药的表观遗传效应

Wu, Yu-Yao; Xu, Yan-Ming; Lau, Andy T Y

Editorial: Characterizing the uncharacterized human proteins

社论:表征未表征的人类蛋白质

Xu, Yan-Ming; Lee, Mee-Hyun; Wong, Chi-Ming; Lau, Andy T Y

Recent knowledge of NFATc4 in oncogenesis and cancer prognosis

NFATc4在肿瘤发生和癌症预后中的最新研究进展

Zhong, Qiu-Hua; Zha, Si-Wei; Lau, Andy T Y; Xu, Yan-Ming